Four-year safety follow-up of the tetravalent dengue vaccine CYD-TDV

被引：6
|
作者：
Wilder-Smith, A. [1 ,2 ]
机构：
[1] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[2] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2018年 / 24卷 / 07期
关键词：
CYD-TDV; Dengue; Safety follow-up; Tetravalent dengue vaccine; Vaccine;
D O I：
10.1016/j.cmi.2018.03.024
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：680 / 681
页数：2
相关论文
共 45 条
  • [31] Adjuvant therapy of renal cell carcinoma patients with an autologous tumor cell lysate vaccine: A 5-year follow-up analysis
    Repmann, R
    Goldschmidt, AJW
    Richter, A
    ANTICANCER RESEARCH, 2003, 23 (2A) : 969 - 974
  • [32] Assessment of Post-Dengue Rheumatic Symptoms Using the WOMAC and DAS-28 Questionnaires in a Honduran Population after a Four-Month Follow-Up
    Zambrano, Lysien I.
    Fuentes-Barahona, Itzel Carolina
    Portillo-Pineda, Ricardo
    Aguilar-Ponce, Melissa
    Murillo-Padilla, Jose Carlos
    Suazo-Menocal, Marlen
    Antunez-Salgado, Cesar
    Medina-Bassilet, Edissa
    Munoz-Lara, Fausto
    Bonilla-Aldana, D. Katterine
    Montenegro-Idrogo, Juan J.
    Rodriguez-Morales, Alfonso J.
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (12)
  • [33] Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique
    Campo, Joseph J.
    Sacarlal, Jahit
    Aponte, John J.
    Aide, Pedro
    Nhabomba, Augusto J.
    Dobano, Carlota
    Alonso, Pedro L.
    VACCINE, 2014, 32 (19) : 2209 - 2216
  • [34] The effects of booster vaccination of hepatitis B vaccine on children 5-15years after primary immunization: A 5-year follow-up study
    Wu, Zikang
    Yao, Jun
    Bao, Hongdan
    Chen, Yongdi
    Lu, Shunshun
    Li, Jing
    Yang, Linna
    Jiang, Zhenggang
    Ren, Jingjing
    Xu, Kai-jin
    Ruan, Bing
    Yang, Shi-gui
    Xie, Tian-sheng
    Li, Qian
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (05) : 1251 - 1256
  • [35] Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination
    Atmar, Robert L.
    Baehner, Frank
    Cramer, Jakob P.
    Lloyd, Eric
    Sherwood, James
    Borkowski, Astrid
    Mendelman, Paul M.
    Al-Ibrahim, Mohamed S.
    Bernstein, David L.
    Brandon, Donald M.
    Chu, Laurence
    Davis, Matthew G.
    Epstein, Robert J.
    Frey, Sharon E.
    Rosen, Jeffrey B.
    Treanor, John J.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (04) : 603 - 614
  • [36] Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up
    Lasagna, Angioletta
    Cassaniti, Irene
    Arena, Francesca
    Bergami, Federica
    Percivalle, Elena
    Comolli, Giuditta
    Sarasini, Antonella
    Ferrari, Alessandro
    Cicognini, Daniela
    Schiavo, Roberta
    Lo Cascio, Giuliana
    Pedrazzoli, Paolo
    Baldanti, Fausto
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [37] Effectiveness and Safety of ANTI SARS-CoV-2 Vaccination in Transplant Patients Treated with Immunosuppressants: A Real-World Pilot Study with a 1-Year Follow-Up
    Caglioti, Alfredo
    Rania, Vincenzo
    Vocca, Cristina
    Marciano, Gianmarco
    Arcidiacono, Valentina
    Catarisano, Luca
    Casarella, Alessandro
    Basile, Emanuele
    Colosimo, Manuela
    Palleria, Caterina
    Mazzuca, Daniela
    Di Mizio, Giulio
    De Sarro, Caterina
    Pileggi, Claudia
    De Sarro, Giovambattista
    Gallelli, Luca
    APPLIED SCIENCES-BASEL, 2022, 12 (12):
  • [38] A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses
    Sohn, Young Mo
    Tandan, J. B.
    Yoksan, Sutee
    Ji, Min
    Ohrr, Heechoul
    VACCINE, 2008, 26 (13) : 1638 - 1643
  • [39] Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study
    Shoemaker, Kathryn
    Soboleva, Karina
    Branche, Angela
    Shankaran, Shivanjali
    Theodore, Deborah A.
    Bari, Muhammad
    Ezeh, Victor
    Green, Justin
    Kelly, Elizabeth
    Lan, Dongmei
    Olsson, Urban
    Saminathan, Senthilkumar
    Shankar, Nirmal Kumar
    Villegas, Berta
    Villafana, Tonya
    Falsey, Ann R.
    Sobieszczyk, Magdalena E.
    VACCINES, 2024, 12 (08)
  • [40] A Focus on Long-Term Follow-Up of Immunoprophylaxis to Recurrent Urinary Tract Infections: 10 Years of Experience with MV140 Vaccine in a Cohort of 1003 Patients Support High Efficacy and Safety
    Sevilla, Cristobal Ramirez
    Lanza, Esther Gomez
    Manzanera, Juan Llopis
    Herrando, Alfredo Cetina
    Pallas, Josep Miquel Puyol
    ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (09): : 753 - 757
12345